Journal of Biological Chemistry · 2002 · 153 citations · 42 references
Life SciencesBiochemistryMolecular BiologyEnzymologyMolecular VirologyVirologyEnzyme FunctionProtein StructureRna Polymerase FunctionViral HepatitisViral ReplicationViral Rna BiologyDna Template RecognitionEnzyme Catalytic MechanismHepatitis C Virus ReplicationHydrophobic InteractionsRna Helicase ActivityViral PolymerasesViral Rna StructureViral Rna Synthesis
The hepatitis C virus (HCV) nonstructural protein 5B (NS5B) is believed to be the central catalytic enzyme responsible for HCV replication but there are many unanswered questions about how its activity is controlled. In this study we reveal that two other HCV proteins, NS3 (a protease/helicase) and NS4B (a hydrophobic protein of unknown function), physically and functionally interact with the NS5B polymerase. We describe a new procedure for generating highly pure NS4B, and use this protein in biochemical studies together with NS5B and NS3. To study the functional effects of the protein-protein interactions, we have developed an in vitro replication assay using the natural noncoding 3′ regions of the respective positive ((+)-3′-untranslated region) and negative ((−)-3′-terminal region) RNA strands of the HCV genome. Our studies show that NS3 dramatically modulates template recognition by NS5B and changes the synthetic products generated by this enzyme. The use of an NTPase-deficient mutant form of NS3 demonstrates that the NTPase activity (and thus helicase activity) of this protein is specifically required for these effects. Moreover, NS4B is found to be a negative regulator of the NS3-NS5B replication complex. Overall, these results reveal that NS3, NS4B, and NS5B can interact to form a regulatory complex that could feature in the process of HCV replication. The hepatitis C virus (HCV) nonstructural protein 5B (NS5B) is believed to be the central catalytic enzyme responsible for HCV replication but there are many unanswered questions about how its activity is controlled. In this study we reveal that two other HCV proteins, NS3 (a protease/helicase) and NS4B (a hydrophobic protein of unknown function), physically and functionally interact with the NS5B polymerase. We describe a new procedure for generating highly pure NS4B, and use this protein in biochemical studies together with NS5B and NS3. To study the functional effects of the protein-protein interactions, we have developed an in vitro replication assay using the natural noncoding 3′ regions of the respective positive ((+)-3′-untranslated region) and negative ((−)-3′-terminal region) RNA strands of the HCV genome. Our studies show that NS3 dramatically modulates template recognition by NS5B and changes the synthetic products generated by this enzyme. The use of an NTPase-deficient mutant form of NS3 demonstrates that the NTPase activity (and thus helicase activity) of this protein is specifically required for these effects. Moreover, NS4B is found to be a negative regulator of the NS3-NS5B replication complex. Overall, these results reveal that NS3, NS4B, and NS5B can interact to form a regulatory complex that could feature in the process of HCV replication. Hepatitis C virus (HCV) 1The abbreviations used are: HCV, hepatitis C virus; UTR, untranslated region; TR, terminal region; RdRp, RNA-dependent RNA polymerase; NS5B, nonstructural protein 5B; NS3, nonstructural protein 3; NS4B, nonstructural protein 4B; PIPES, 1,4-piperazinediethanesulfonic acid; MOPS, 4-morpholinepropanesulfonic acid; BSA, bovine serum albumin; Ni-NTA, nickel-nitrilotriacetic acid.1The abbreviations used are: HCV, hepatitis C virus; UTR, untranslated region; TR, terminal region; RdRp, RNA-dependent RNA polymerase; NS5B, nonstructural protein 5B; NS3, nonstructural protein 3; NS4B, nonstructural protein 4B; PIPES, 1,4-piperazinediethanesulfonic acid; MOPS, 4-morpholinepropanesulfonic acid; BSA, bovine serum albumin; Ni-NTA, nickel-nitrilotriacetic acid.is a major pathogen of parenterally transmitted non-A, non-B hepatitis (1Choo Q.L. Kuo G. Weiner A.J. Overby L.R. Bradley D.W. Houghton M. Science. 1989; 244: 359-362Google Scholar) and often causes the development of malignant chronic disease, including liver cirrhosis and hepatocellular carcinoma (2Shimotohno K. Semin. Cancer Biol. 2000; 10: 233-240Google Scholar). With nearly 3% of the population of the world infected with HCV and no protective vaccine available at present, this disease has emerged as a serious global health problem since the virus was first identified (3Sarbah S.A. Younossi Z.M. J. Clin. Gastroenterol. 2000; 30: 125-143Google Scholar, 4World Health Organization J. Viral Hepat. 1999; 6: 35-47Google Scholar). HCV is a positive-stranded RNA virus with a genome of ∼9400 bp. This genomic RNA initially directs the synthesis of at least 10 structural and nonstructural viral proteins (5Reed K.E. Rice C.M. Curr. Top. Microbiol. Immunol. 2000; 242: 55-84Google Scholar). Following that, it is utilized by the viral RNA-dependent RNA polymerase (the nonstructural protein 5B; NS5B) as template to generate a complementary negative-stranded RNA. Once synthesized, the negative strands are transcribed into new molecules of positive-stranded genomic RNA, which in turn provide additional templates for viral protein synthesis as well as genomic RNA for the production of progeny virus (5Reed K.E. Rice C.M. Curr. Top. Microbiol. Immunol. 2000; 242: 55-84Google Scholar, 6Rosenberg S. J. Mol. Biol. 2001; 313: 451-464Google Scholar). However, the molecular events that mediate this process remain largely unclear. Several attempts to dissect the mechanistic details of the viral replication cycle have been reported to date. The focal point of such investigations has been NS5B, which possesses an RNA-dependent RNA polymerase (RdRp) activity and is believed to be the key enzyme catalyzing HCV RNA synthesis (7Lohmann V. Overton H. Bartenschlager R. J. Biol. Chem. 1999; 274: 10807-10815Google Scholar, 8Behrens S.E. Tomei L. De Francesco R. EMBO J. 1996; 15: 12-22Google Scholar, 9Qin W. Luo H. Nomura T. Hayashi N. Yamashita T. Murakami S. J. Biol. Chem. 2002; 277: 2132-2137Google Scholar, 10Qin W. Yamashita T. Shirota Y. Lin Y. Wei W. Murakami S. Hepatology. 2001; 33: 728-737Google Scholar, 11Moradpour D. Bieck E. Hugle T. Wels W. Wu J.Z. Hong Z. Blum H.E. Bartenschlager R. J. Biol. Chem. 2002; 277: 593-601Google Scholar, 12Reigadas S. Ventura M. Sarih-Cottin L. Castroviejo M. Litvak S. Astier-Gin T. Eur. J. Biochem. 2001; 268: 5857-5867Google Scholar, 13Blight K.J. Kolykhalov A.A. Rice C.M. Science. 2000; 290: 1972-1974Google Scholar, 14Hwang S.B. Park K.J. Kim Y.S. Sung Y.C. Lai M.M. Virology. 1997; 227: 439-446Google Scholar). Its crystal structure reveals that it contains the classical finger, palm, and thumb subdomains of the polymerases with the unique feature of a more fully enclosed active site tunnel (15Ago H. Adachi T. Yoshida A. Yamamoto M. Habuka N. Yatsunami K. Miyano M. Structure Fold Des. 1999; 7: 1417-1426Google Scholar, 16Bressanelli S. Tomei L. Roussel A. Incitti I. Vitale R.L. Mathieu M. De Francesco R. Rey F.A. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 13034-13039Google Scholar, 17Lesburg C.A. Cable M.B. Ferrari E. Hong Z. Mannarino A.F. Weber P.C. Nat. Struct. Biol. 1999; 6: 937-943Google Scholar), and a recent report by Bressanelli and colleagues (18Bressanelli S. Tomei L. Rey F.A. De Francesco R. J. Virol. 2002; 76: 3482-3492Google Scholar) has provided additional information about the complex of NS5B with ribonucleotides. Recombinant NS5B protein from different sources has been shown to replicate a range of natural and synthetic RNA templates, both in a primer-dependent and primer-independent fashion (19Hong Z. Cameron C.E. Walker M.P. Castro C. Yao N. Lau J.Y. Zhong W. Virology. 2001; 285: 6-11Google Scholar, 20Zhong W. Ferrari E. Lesburg C.A. Maag D. Ghosh S.K. Cameron C.E. Lau J.Y. Hong Z. J. Virol. 2000; 74: 9134-9143Google Scholar, 21Zhong W. Uss A.S. Ferrari E. Lau J.Y. Hong Z. J. Virol. 2000; 74: 2017-2022Google Scholar, 22Tomei L. Vitale R.L. Incitti I. Serafini S. Altamura S. Vitelli A. De Francesco R. J. Gen. Virol. 2000; 81: 759-767Google Scholar, 23Oh J.W. Sheu G.T. Lai M.M. J. Biol. Chem. 2000; 275: 17710-17717Google Scholar, 24Luo G. Hamatake R.K. Mathis D.M. Racela J. Rigat K.L. Lemm J. Colonno R.J. J. Virol. 2000; 74: 851-863Google Scholar, 25Kao C.C. Yang X. Kline A. Wang Q.M. Barket D. Heinz B.A. J. Virol. 2000; 74: 11121-11128Google Scholar). Because NS5B does not discriminate against nonviral RNA templatesin vitro, signal sequences present in the 3′-terminal regions of the genomic and antigenomic RNA as well as viral and/or cellular factors most likely confer the specificity of NS5B for viral replication in vivo. Furthermore, localization of the replication complexes to specific cellular compartments might also impose a degree of selectivity for the viral RNA. Recently, it has been suggested that NS5B guides the replication complex to the ER membrane (26Schmidt-Mende J. Bieck E. Hugle T. Penin F. Rice C.M. Blum H.E. Moradpour D. J. Biol. Chem. 2001; 276: 44052-44063Google Scholar). Even though recent evidence has indicated that NS5B associates with other HCV viral proteins, including NS3, NS4A, and S. T. H. Biochem. 244: Scholar, Y. Luo H. W. S. Yamashita T. K. Murakami S. J. Biol. Chem. 2002; 277: Scholar), the of these proteins the NS5B activity has been with the that a recent report has indicated that modulates NS5B activity Y. Luo H. W. S. Yamashita T. K. Murakami S. J. Biol. Chem. 2002; 277: Scholar). NS3 possesses a in the of the protein and an that in the (5Reed K.E. Rice C.M. Curr. Top. Microbiol. Immunol. 2000; 242: 55-84Google Scholar). In vitro that of NS3 is for helicase activity S.K. J. Biol. Chem. Scholar, E. S. Hong J. Virol. 2001; Scholar, J. Biol. Chem. 1999; 274: Scholar). Its helicase activity has been shown to be of the that NS3 is a of the replication complex A.A. K. Rice C.M. J. Virol. 2000; 74: Scholar). However, the of of NS3 in replication is not The hydrophobic protein NS4B is also to interact with the replication complex. However, this protein is the least of the HCV proteins and has no is with the membrane T. F. Bieck E. M. Rice C.M. Blum H.E. Moradpour D. Virology. 2001; Scholar) and has been in the of A. De Francesco R. J. Virol. 1999; Scholar). has the to in with the C. Y. Park J. H. J. Virol. 2002; Scholar) and it has been reported that NS4B the cellular J. N. Yoshida H. S.K. Y. M. J. Virol. 2002; Scholar). has also been suggested that NS4B associates with NS3 its with C. Wu J.W. K. J. Virol. 1997; Scholar). However, evidence for an with NS3 has been In this we the that NS3 and NS4B of an HCV replication complex. We have biochemical evidence for NS3 and NS5B as well as NS3 and Moreover, the of NS3 and NS4B proteins the activity of the viral polymerase was the 3′-terminal of the viral the and used as templates in an in vitro replication in which the effects of NS3 and NS4B NS5B Our that both proteins the NS5B activity in The sequences to the 3′ of the and RNA strands of HCV from the and provided by using the and for the and for the The products from these into the The positive and the in the the K. Scholar) in and The to the was from the The to a RNA polymerase in the The was in of the The contains the NS3 from into of the the of the The NS3 was using from as template and the two and the used for the and the and are in contains the NS5B from into the of the the two and the used for the and the and are in is the and was to the NS4B protein with a at the in The NS4B from was by using as template the and the and the used for the and the and are in the of NS5B, with (a of which the of NS5B as in V. F. U. Bartenschlager R. J. Virol. 1997; Scholar). E. at in to an of at was to a of and the for additional at and by and at of NS5B, the in 10 and and a The NS5B protein was using a of The with the NS5B against a and and a a of was used to the and the with the NS5B against a and and using a was used to generate using the and the was used to at a of of The in 10 and and the protein was using a of was used to the The with the NS4B against a and and using an a with an The most a and using a of against a and and using a NS3 was using an procedure A.J. Wei L. Cameron C.E. 2001; Scholar). the of RNA templates for of the and and transcribed in vitro using RNA polymerase in the with which in to be the for The was for at the was a to the RNA from the RNA and the The RNA was by and from the in of RNA and for at The by at for 10 and the was with and in using and with The using these templates the generated by activity the In the of NS5B protein with of RNA template in a of and for 10 at additional proteins of NS3 NS4B first with the RNA template for 10 at by of NS5B protein for an additional 10 at The by the of a of of and with 10 of and for at of was to the to the of the the products with with of and with The was in a 10 at for and an the and to In the products with for and to In this of first with of the RNA and in a PIPES, The was at for and at The RNA in of and utilized for a NS5B assay as using a of a of the of and of NS3 was by the in to a using the using 10 MOPS, 10 10 BSA, and 10 at of was at for The NS5B products to a membrane and at in The membrane was for at and to a of at The was in 10 of and 10 at together with the RNA The was by the membrane from to at The products using a The was used in a to the at for in the of was as M. S.B. N. Lai M.M. Virology. 1996; Scholar). NS4B, and NS5B, BSA, and protein proteins to a and to a The with and and with for at and with and for to the The membrane was for at with and 3% in The in vitro HCV NS5B, NS3, proteins with the membrane in 3% and at proteins by with and was by In to for of to of protein to the to the The E. D. Scholar) by of protein in well at with for at protein was the for at at a of in with and for using an In the first was from the with was in the at the of this NS4B was not available as a and we to a new procedure for generating this NS4B protein was at the with a and using a in NS4B as a protein in and was found to to not The protein was using a and using an The protein was a and the a that this protein was by an NS5B was also generated as a protein in E. and using of NS3 was to a procedure A.J. Wei L. Cameron C.E. 2001; Scholar) We the the HCV nonstructural proteins using a of we protein In this HCV NS5B NS4B and NS3 helicase protein to and to a the membrane and with in HCV NS3 protein NS5B protein of two other proteins also to the membrane in these as protein and was found to to NS4B, NS5B, and to its helicase but not to protein and was to to and to and and to NS4B no with protein could be and in which was used to by RNA that the not RNA Moreover, in a we the membrane with a form of the this no signal with of the proteins The of NS3 to interact with NS4B NS5B was by of a assay NS3 was in and to with NS4B NS5B, which in turn using an This the NS3 and NS5B and NS3 and NS4B The was also with NS4B and NS5B in and the NS3 protein was using an not with the other NS3 was found to to both NS5B and In assay and of for the proteins no positive with these the by the the respective proteins and RNA. also that additional proteins to the of the replication complex. Because there is evidence that at least NS5B and NS3 as J. Biol. Chem. 1999; 274: Scholar, Q.M. K. J. S. F. R. K. J. Virol. 2002; 76: Scholar) about the of the respective of this complex. NS5B is to RNA synthesis specific and templates, both in a primer-dependent and primer-independent However, it has been shown that NS5B most likely as the these are the of and RNA, (19Hong Z. Cameron C.E. Walker M.P. Castro C. Yao N. Lau J.Y. Zhong W. Virology. 2001; 285: 6-11Google Scholar, 20Zhong W. Ferrari E. Lesburg C.A. Maag D. Ghosh S.K. Cameron C.E. Lau J.Y. Hong Z. J. Virol. 2000; 74: 9134-9143Google Scholar, 21Zhong W. Uss A.S. Ferrari E. Lau J.Y. Hong Z. J. Virol. 2000; 74: 2017-2022Google Scholar, 23Oh J.W. Sheu G.T. Lai M.M. J. Biol. Chem. 2000; 275: 17710-17717Google Scholar, 24Luo G. Hamatake R.K. Mathis D.M. Racela J. Rigat K.L. Lemm J. Colonno R.J. J. Virol. 2000; 74: 851-863Google Scholar, 25Kao C.C. Yang X. Kline A. Wang Q.M. Barket D. Heinz B.A. J. Virol. 2000; 74: 11121-11128Google J.W. T. Lai M.M. J. Virol. 1999; Scholar). Moreover, the structure by an RNA template is likely to we it to use natural template sequences with the template We generated HCV RNA to the 3′ regions of the respective positive and negative strands of the HCV RNA. Moreover, to the both RNA templates, the two 3′ regions to the The in vitro as and the from the a not The are to in this as the positive and the negative 3′-terminal The template used to RNA the is for a and for a C We RNA synthesis by the NS5B protein in a assay using the new 3′ RNA was the was used as template not In NS5B generated the positive provided with the RNA as template This is and the that was used as a The was generated using the template indicated in at the 3′ with (and was not in to the RNA used as the template for NS5B also generated a with in together with a that was not in the To the two major products of NS5B activity to terminal we not the products with RNA, both against thus the of the complementary in the by Because was to the template RNA, was that it a of NS5B polymerase. However, a by S.E. Tomei L. De Francesco R. EMBO J. 1996; 15: 12-22Google Scholar) to is a RNA generated by synthesis at the of the first We the products to a 8Behrens S.E. Tomei L. De Francesco R. EMBO J. 1996; 15: 12-22Google Scholar). The was (and the the template by and colleagues S.E. Tomei L. De Francesco R. EMBO J. 1996; 15: 12-22Google Scholar), NS5B is of at least RNA that the of the by Luo and colleagues G. Hamatake R.K. Mathis D.M. Racela J. Rigat K.L. Lemm J. Colonno R.J. J. Virol. 2000; 74: 851-863Google Scholar) also the that to a of In these it is that the NS5B generated a of RNA of the but from NS5B to that NS5B does not terminal polymerase activity the RNA templates in this terminal activity be to in the of a of However, no of template RNA was such in to the of products present is evidence that of terminal activity with NS5B in to from the used to the protein V. F. U. Bartenschlager R. J. Virol. 1997; Scholar). that NS3 physically with NS5B we the there is also a functional The of NS3 to the RNA-dependent RNA synthesis assay results In the of NS3, the was a template for This is with other recent results from and colleagues S. Ventura M. Sarih-Cottin L. Castroviejo M. Litvak S. Astier-Gin T. Eur. J. Biochem. 2001; 268: 5857-5867Google Scholar). However, with of NS3 to the we the of a new molecular the of which in to the of The NS3 helicase was also found of NS5B to generate this new The was and we for to the for the In we that the of NS3 also the generated from the template was the of an additional molecular in NS3 protein was to the The of this with of NS3. The new was NS3 helicase was used of the NS3 the products to a and both to more the template To this new molecular RNA was a of RNA we of the products with the RNA as the used in a RNA with the that this new contains the complementary to the template In a of the products with by This not the of the and that these are not complexes and In the we 3′ of replication to generate the RNA We the using complementary to the of the RNA templates the and/or of the a RNA complementary to the the template was used in the the molecular RNA products However, with the template there was an in the of RNA at the of the RNA generated with the This that there could be the and the RNA, by NS5B However, RNA was in the of an RNA This was most likely of the and with 3′ RNA for the by can be found in the structure of NS5B, which a unique in the thumb that the active site of the enzyme. This as a that at a 3′ (19Hong Z. Cameron C.E. Walker M.P. Castro C. Yao N. Lau J.Y. Zhong W. Virology. 2001; 285: 6-11Google Scholar). The of NS3 was in the of a of and and the was The of the molecular products with a was at and Because the for and are and the of not the of RNA that the helicase activity is to it was to this of the of the NS5B activity was to the helicase activity of NS3. To this we used a mutant form of NS3 which is in The protein has in the NTPase that both the NTPase and helicase shown in this mutant form of NS3 not NS5B to generate the additional products from the template that the other of the protein both NS5B by and by of to from are fully with the that the changes in the and of RNA products in the of NS3 are to the activity of the helicase We also that NS4B is of a complex with NS3, and to this a The results of replication that NS4B the of NS3 NS5B, the of the additional molecular that is generated by of of RNA synthesis the of the complementary NS4B as a regulator of the replication activity that the of RNA products that are generated by To this we NS4B NS3 activity a assay we found that NS4B as an of the NS3 NTPase in the of and 10 NS3, the of NS4B to NS3 the of from to these results that NS4B is a negative regulator of NS3 it from NS5B This be to an functional NS4B and the NS3 NTPase also of NS3, that its activity with of the However, of the of the NS3 the positive of NS3 and the of NS4B We from the results reported that NS3 and NS4B as of of NS5B in the of a replication complex. NS3 physically with NS5B to structure in the RNA template and thus to both synthesis and of the replication the first template by the polymerase a The synthesis of products that of the template by NS5B has been S. Ventura M. Sarih-Cottin L. Castroviejo M. Litvak S. Astier-Gin T. Eur. J. Biochem. 2001; 268: 5857-5867Google Scholar). a of these products is not the of the present the results of and that of the positive and negative sequences by the be in to the structure and of these complex to we that hepatitis virus molecular of RNA, which are in turn into and Lai M.M. J. Virol. 2002; 76: Scholar). NS4B, the other NS5B by of its with NS3, and also to NS5B does NS4B the NTPase activity of NS3, but it also the of NS3. This as the of the molecular RNA products Moreover, in the of NS4B, the complex to show a to generate the of the In other in the NS3 both complementary RNA synthesis by NS5B and to the synthesis that the molecular RNA Overall, it is that there is an NS3 and NS4B HCV replication that for of the RNA products generated by the polymerase. The of this could to the of the HCV We not the of of However, in its is at least to its the NTPase activity that is with the NS3 helicase and also be a NS4B and In the of a fully functional NS3 have a to template RNA to the NS5B active The replication by NS5B of RNA RNA has been reported S. Ventura M. Sarih-Cottin L. Castroviejo M. Litvak S. Astier-Gin T. Eur. J. Biochem. 2001; 268: 5857-5867Google Scholar), this study not use HCV RNA templates the In this to provide an as to how HCV might an of positive negative RNA in vivo. However, results also show that this template is in the of NS3 This the of the NS3 helicase activity a replication complex together with the of to the NS3 the and of the HCV polymerase. has also been by S.E. Tomei L. De Francesco R. EMBO J. 1996; 15: 12-22Google Scholar), NS5B is of generating at least RNA that the of the template in the of NS3, the polymerase a of more complex products from both templates In the of the that NS4B the NS3 NS5B, it more likely that the NS4B and NS3 be a of the of the positive and negative the it is to that NS3 is a RNA and that is required to this activity E. EMBO J. 2002; Scholar) also it is that a of the replication cycle in HCV of the and functional NS5B and the other proteins that its other recent studies have indicated how and might in the replication the present study has provided into the of NS3 and The are both positive and in the these provide a for the of HCV replication. also be to the of the to degree are by the of NS4B in infected and thus to feature in the HCV replication We and from for of the and and the NS3 helicase We also and for of NS3. with the of
42
Antibodies, a laboratory manual
Biomedicine & Pharmacotherapy · 1989 · 12.5K citations
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Qui‐Lim Choo, George Kuo, Amy J. Weiner et al. · Science · 1989 · 6.9K citations
Crystal structure of a hepatitis delta virus ribozyme
A.R. Ferré-D′Amaré, Kaihong Zhou, Jennifer A. Doudna · Nature · 1998 · 780 citations